Published in Hepatology on September 01, 1997
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut (2005) 5.39
The metastatic niche: adapting the foreign soil. Nat Rev Cancer (2009) 5.28
Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev (2008) 2.95
DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell (2015) 1.66
The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer (2012) 1.46
Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol (2005) 1.22
The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16
MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation. Sci Rep (2013) 1.09
The prometastatic microenvironment of the liver. Cancer Microenviron (2008) 1.08
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem (2012) 1.07
The role of the tumor microenvironment in regulating angiogenesis. Cold Spring Harb Perspect Med (2012) 0.93
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut (2006) 0.92
Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis Tissue Repair (2011) 0.89
Cancer-associated fibroblasts in digestive tumors. World J Gastroenterol (2014) 0.87
Promotion of colon cancer metastases in rat liver by fish oil diet is not due to reduced stroma formation. Clin Exp Metastasis (2000) 0.85
Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma. Biomed Res Int (2014) 0.84
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy. EBioMedicine (2017) 0.83
Adult stem cels and their niches. Adv Exp Med Biol (2010) 0.83
Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2. Clin Exp Metastasis (2012) 0.83
Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases. Clin Exp Metastasis (2002) 0.83
Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile. Sci Rep (2016) 0.81
The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron (2011) 0.81
Discovery of endothelium and mesenchymal properties of primo vessels in the mesentery. Evid Based Complement Alternat Med (2013) 0.81
Liver metastases: Microenvironments and ex-vivo models. Exp Biol Med (Maywood) (2016) 0.78
The diverse roles of the TNF axis in cancer progression and metastasis. Trends Cancer Res (2016) 0.77
Tungsten targets the tumor microenvironment to enhance breast cancer metastasis. Toxicol Sci (2014) 0.77
The pre-metastatic niche: is metastasis random? Bonekey Rep (2012) 0.76
The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation. Biomolecules (2015) 0.75
Cell proliferation downregulated by TGF-β2-triggered G1/S checkpoint in clinical CAFs. Cell Cycle (2016) 0.75
Isolation of microtubule protein from cultured mouse neuroblastoma cells. Proc Natl Acad Sci U S A (1970) 4.20
Careers. Competition and careers in biosciences. Science (2001) 2.45
The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J Biol Chem (1974) 2.40
Reversible restoration of the birefringence of cold-treated, isolated mitotic apparatus of surf clam eggs with chick brain tubulin. Nature (1974) 2.08
Practical implications of coexistent different technologies in clinical chemical laboratories. Solid phase chemistry and conventional analysis. Eur J Clin Chem Clin Biochem (1991) 1.96
Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology (2000) 1.84
The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (1987) 1.84
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62
The use of theory based semistructured elicitation questionnaires: formative research for CDC's Prevention Marketing Initiative. Public Health Rep (1996) 1.61
A Case of Malignant Exophthalmos. Can Med Assoc J (1937) 1.61
Moraxella infectious arthritis: first report in an adult. Ann Rheum Dis (1980) 1.58
General morphology and capsid fine structure of African swine fever virus particles. Virology (1984) 1.52
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Are tiny polyps important when found on sigmoidoscopy in asymptomatic people? J Clin Gastroenterol (1992) 1.41
[The clinical value of laminin determination in advanced liver cirrhosis]. Dtsch Med Wochenschr (1996) 1.39
Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem (1997) 1.35
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology (2001) 1.29
Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology (2006) 1.28
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol (1997) 1.28
Reiter's syndrome following epidemic shigellosis. J Rheumatol (1982) 1.23
Structure of the head-tail connector of bacteriophage phi 29. J Mol Biol (1982) 1.21
Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med (1999) 1.21
Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology (1998) 1.19
Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci (1995) 1.19
Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors (2005) 1.18
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology (1995) 1.18
Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol (1999) 1.17
Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 1.15
Computer graphic display method for visualizing three-dimensional biological structures. Science (1986) 1.14
Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology (1993) 1.12
Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology (1997) 1.12
Influence of glucagon and cyclic adenosine 3':5'-monophosphate on the phosphorylation of rat liver ribosomal protein S6. J Biol Chem (1976) 1.11
Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut (2005) 1.11
Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest (1995) 1.10
Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol (1999) 1.10
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut (2004) 1.10
Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology (1994) 1.08
The nucleotide sequence of Drosophila melanogaster copia-specific 2.1-kb mRNA. Nucleic Acids Res (1989) 1.07
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Arch Gen Psychiatry (1998) 1.07
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med (2007) 1.07
Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology (2001) 1.06
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet (2007) 1.06
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat (2009) 1.05
Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. Br J Clin Pharmacol (1984) 1.04
Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol (2001) 1.04
Molecular and functional aspects of latent transforming growth factor-beta binding protein: just a masking protein? Cell Tissue Res (1999) 1.04
Diffuse retinal hemorrhages (ocular decompression syndrome) after trabeculectomy with mitomycin C for neovascular glaucoma. Acta Ophthalmol Scand (2000) 1.03
The stimulation of the phosphorylation of ribosomal protein S6 by cycloheximide and puromycin. Biochem Biophys Res Commun (1974) 1.03
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry (1997) 1.03
Genetic polymorphism at the CLOCK gene locus and major depression. Am J Med Genet (2000) 1.02
The effects of a continuing medical education programme in interpersonal communication skills on doctor practice and patient satisfaction in Trinidad and Tobago. Med Educ (1998) 1.01
Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J Hepatol (1998) 1.00
Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology (1997) 1.00
Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin Chim Acta (1986) 1.00
Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem (1999) 0.99
Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol (2001) 0.99
The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med (2013) 0.98
[Mechanisms of hepatic fibrogenesis]. Arch Pediatr (2002) 0.98
Three-dimensional reconstruction of bacteriophage phi 29 neck particles at 2 X 2 nm resolution. J Mol Biol (1985) 0.98
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol (1996) 0.98
Interaction of synthetic polynucleotides with small rat liver ribosomal subunits possessing low and highly phosphorylated protein S6. Biochim Biophys Acta (1980) 0.97
Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun (2006) 0.97
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem (2007) 0.97
Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis. Ann Rheum Dis (1980) 0.97
Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation (2008) 0.97
Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology (1998) 0.96
Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology (1995) 0.95
A role for thrombin in liver fibrosis. Gut (2004) 0.95
Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin Exp Metastasis (1999) 0.95
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun (2001) 0.94
LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem J (2001) 0.94
Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6. Nature (1976) 0.93
Fibronectin is synthesized as an acute phase reactant in rat hepatocytes. J Clin Chem Clin Biochem (1986) 0.93
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med (2006) 0.93
Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest (1999) 0.93
Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun (1990) 0.93
(Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology (1998) 0.93
Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem (1989) 0.92
Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun (1989) 0.92
Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts. Eur J Clin Chem Clin Biochem (1996) 0.92
Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease. Am J Pathol (1995) 0.91
Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology (1999) 0.91
Plasma von Willebrand factor in connective tissue disease. Ann Rheum Dis (1987) 0.91
Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology (1997) 0.91
Outcome definitions and predictors in depression. Psychother Psychosom (1998) 0.90
Differential expression of keratan sulphate proteoglycans fibromodulin, lumican and aggrecan in normal and fibrotic rat liver. FEBS Lett (1992) 0.90
Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J Clin Chem Clin Biochem (1986) 0.90
Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver. Hepatology (2001) 0.90
Quantitative monitoring of the mRNA expression pattern of the TGF-beta-isoforms (beta 1, beta 2, beta 3) during transdifferentiation of hepatic stellate cells using a newly developed real-time SYBR Green PCR. Biochem Biophys Res Commun (2002) 0.89
Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells. Hepatology (1998) 0.89
Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol (1999) 0.89
Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem (1991) 0.89
The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol (1993) 0.88
Structure of phage phi 29 connector protein assembled in vivo. Virology (1985) 0.88
The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells. J Clin Chem Clin Biochem (1989) 0.88